Abstract:
The present invention relates to a pharmaceutical composition containing a vector for treating immune diseases, which expresses bispecific proteins containing anti-IL-6R and TNFR2. The pharmaceutical composition of the present invention relates to a pharmaceutical composition for preventing and treating autoimmune diseases, containing (a) a gene expression cassette; (b) a site-specific recombinant region located at the outside of the gene expression cassette; and (c) a non-viral vector which does not contain a replication origin and a selection marker gene.
Abstract:
The present invention relates to a stem cell therapeutic agent containing a minicircle vector which expresses physiologically active proteins and, more particularly, to stem cells containing a minicircle vector which expresses physiologically active proteins and a pharmaceutical composition and a composition for drug delivery containing the same.
Abstract:
The present invention relates to a stem cell containing an anti-IL-6R-expressing vector. More particularly, the present invention relates to a stem cell containing a minicircle vector expressing the anti-il-6r-expressing vector; and a pharmaceutical composition for treating an autoimmune disease.